Search Results

Containing any of the words

Only of the type

An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus platinum doublet chemotherapy versus platinum doublet chemotherapy in Subjects with Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Drug Clinical Trial

AN OPEN-LABEL, SINGLE-ARM 4-YEAR STUDY TO EVALUATE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB TREATMENT IN PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS Drug Clinical Trial

Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers Drug Clinical Trial

A phase III randomized clinical trial comparing post-transplant cyclophosphamide with calcineurin inhibitors as a GVHD prophylaxis to standard care of methotrexate and calcineurin inhibitors for acute leukemia incorporating patient pharmacogenomic profiling – a personalized medicine approach in allogeneic hematopoietic cell transplantation PMAT Drug Clinical Trial

A Prospective, Multicenter, Single-Arm, Open-Label, Phase 3 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging. (RESTORE) Drug Clinical Trial

Safety Signal of Etoposide and Risk of Electrolyte imbalance Safety Alert

Treatment of Neuroendocrine Tumors (NETs) with combination of Everolimus and Radiolabeld Somatostatin Analogue" Drug Clinical Trial

Safety Signal of Docetaxel and Risk of Rhabdomyolysis Safety Alert

Emtricitabine, Elvitegravir , Cobicistat ,Tenofovir, Alafenamide Risk Minimization Activity - New

Agomelatine Risk Minimization Activity - New